Aktiespot

Nectar Lifesciences Limited (NECTAR LIFESCIENCES LTD.) aktie

NECLIFE.NS

₹12.05+0.07 (+0.58%)
Laddar diagram...

NECTAR LIFESCIENCES LTD.

Öppning11.98
Högsta12.15
Lägsta11.86
Volym196.87k
P/EN/A
Börsvärde2.34B
52 veckors högsta25.50
52 veckors lägsta9.30
Genomsnittlig volym425.99k
UtdelningN/A
BetaN/A
EPS-2.62

Om Nectar Lifesciences Limited (NECTAR LIFESCIENCES LTD.) aktie

Nectar Lifesciences Limited manufactures, distributes, markets and sells pharmaceutical products in India and internationally. The company offers cephalosporins, includes pharmaceutical ingredients and intermediates comprising cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium, ceftriaxone sodium, cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil and sterile, cefprozil, cefdinir, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate, and cefepime +Arginine. It also provides contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspensions, and granules and injectable for cephalosporins. In addition, the company offers menthol and pearl capsules. Nectar Lifesciences Limited was incorporated in 1995 and is headquartered in Chandigarh, India.

Företagsinformation

Börs: NSE (NSI)
Sektor: Sundhed
Industri: Lægemiddelproducenter – Special og generisk
Adress:
Plot No. 110
160002 Chandigarh, India

Analytikernas aktierekommendationer

Denna översikt ger en snabb insikt i hur analytiker bedömer aktiens potential baserat på deras senaste analyser och kursmål.

Lägsta kursmål
Genomsnittligt kursmål
Median kursmål
Högsta kursmål

Andra tittar också på: